Quoin Pharmaceuticals Investor Relations Material
Latest events
Q4 2023
Quoin Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Quoin Pharmaceuticals Ltd
Access all reports
Quoin Pharmaceuticals Ltd is a U.S.-based specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases. The company’s lead programs target conditions such as Netherton syndrome and other rare skin disorders. Quoin develops its drug candidates using proprietary delivery technologies and aims to address high unmet medical needs through both clinical research and strategic partnerships. The company is headquartered in Ashburn, Virginia, and its shares are listed on the NASDAQ.
Key slides for Quoin Pharmaceuticals Ltd
Corporate Presentation
Quoin Pharmaceuticals Ltd
Corporate Presentation
Quoin Pharmaceuticals Ltd
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
QNRX
Country
🇺🇸 United States